Skip to main content
Erschienen in: International Journal of Colorectal Disease 5/2015

01.05.2015 | Original Article

Increased risk of stroke among patients with Crohn’s disease: a population-based matched cohort study

verfasst von: Joseph Jordan Keller, Jui Wang, Ya-Li Hwang, Chia-Chi Chou, Li-Hsuan Wang, Jung-Lung Hsu, Chyi-Huey Bai, Hung-Yi Chiou

Erschienen in: International Journal of Colorectal Disease | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Crohn’s disease (CD) is one type of inflammatory bowel disease (IBD) that has been speculated to share prognostic factors with the development of stroke. There is controversial information in the literature regarding the association between CD and stroke. The present cohort study estimated the risk of subsequent stroke among CD patients compared with matched comparison subjects drawn from a population-based dataset in Taiwan.

Method

This study drew data from the Taiwan National Health Insurance Database to conduct a historical cohort study. The study cohort comprised 3309 CD patients, and the comparison cohort comprised 13,236 subjects without an IBD. Cox proportional hazards regressions were performed to estimate the risk of subsequent stroke during the follow-up period. We also conducted additional analyses stratifying by age group and gender.

Results

After adjusting for selected medical co-morbidities and recent prescriptions of selected pharmaceuticals, the hazard ratio (HR) for subsequent stroke among patients with CD was found to be 1.911 (95 % confidence interval (CI) = 1.65–2.22) that of comparison subjects. While we did not detect an association between stroke and CD among patients aged 30–40 years, we did detect increased risks for stroke among CD patients aged 40–50 years (HR = 2.29) and those aged over 50 years (HR = 1.88). We also found women (HR = 2.39) to be at a greater risk than men (HR = 1.50).

Conclusion

This study reports an increased HR for subsequent stroke among CD patients when compared to matched comparison patients without IBD in an Asian population.
Literatur
1.
Zurück zum Zitat Loftus EV Jr, Schoenfeld P, Sandborn WJ (2002) The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 16:51–60CrossRefPubMed Loftus EV Jr, Schoenfeld P, Sandborn WJ (2002) The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 16:51–60CrossRefPubMed
2.
Zurück zum Zitat Tan VP, Chung A, Yan BP, et al (2013) Review article: venous and arterial disease in inflammatory bowel disease. J Gastroenterol Hepatol Tan VP, Chung A, Yan BP, et al (2013) Review article: venous and arterial disease in inflammatory bowel disease. J Gastroenterol Hepatol
3.
Zurück zum Zitat Magro F, Dinis-Ribeiro M, Araújo FM et al (2003) High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 15:1157–1163CrossRefPubMed Magro F, Dinis-Ribeiro M, Araújo FM et al (2003) High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 15:1157–1163CrossRefPubMed
4.
Zurück zum Zitat Grainge MJ, West J, Card TR (2010) Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 375:657–63CrossRefPubMed Grainge MJ, West J, Card TR (2010) Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 375:657–63CrossRefPubMed
5.
Zurück zum Zitat Koutroubakis IE, Sfiridaki A, Tsiolakidou G et al (2007) Genetic risk factors in patients with inflammatory bowel disease and vascular complications: case–control study. Inflamm Bowel Dis 13:410–415CrossRefPubMed Koutroubakis IE, Sfiridaki A, Tsiolakidou G et al (2007) Genetic risk factors in patients with inflammatory bowel disease and vascular complications: case–control study. Inflamm Bowel Dis 13:410–415CrossRefPubMed
6.
Zurück zum Zitat Andersohn F, Waring M, Garbe E (2010) Risk of ischemic stroke in patients with Crohn’s disease: a population-based nested case–control study. Inflamm Bowel Dis 16:1387–1392CrossRefPubMed Andersohn F, Waring M, Garbe E (2010) Risk of ischemic stroke in patients with Crohn’s disease: a population-based nested case–control study. Inflamm Bowel Dis 16:1387–1392CrossRefPubMed
7.
Zurück zum Zitat Miehsler W, Reinisch W, Valic E et al (2004) Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53:542–8CrossRefPubMedCentralPubMed Miehsler W, Reinisch W, Valic E et al (2004) Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53:542–8CrossRefPubMedCentralPubMed
8.
Zurück zum Zitat Santos S, Casadevall T, Pascual LF et al (2001) Neurological alterations related to Crohn’s disease. Rev Neurol 32:1158–1162PubMed Santos S, Casadevall T, Pascual LF et al (2001) Neurological alterations related to Crohn’s disease. Rev Neurol 32:1158–1162PubMed
9.
Zurück zum Zitat Lozano R, Naghavi M, Foreman K et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–128CrossRefPubMed Lozano R, Naghavi M, Foreman K et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–128CrossRefPubMed
10.
Zurück zum Zitat Murray CJL, Vos T, Lozano R et al (2012) Disability-adjusted life-years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2197–223CrossRefPubMed Murray CJL, Vos T, Lozano R et al (2012) Disability-adjusted life-years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2197–223CrossRefPubMed
11.
Zurück zum Zitat Bernstein CN, Wajda A, Blanchard JF (2008) The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol 6:41–45CrossRefPubMed Bernstein CN, Wajda A, Blanchard JF (2008) The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol 6:41–45CrossRefPubMed
12.
Zurück zum Zitat Talbot RW, Heppell J, Dozois RR et al (1986) Vascular complications of inflammatory bowel disease. Mayo Clin Proc 61:140–145CrossRefPubMed Talbot RW, Heppell J, Dozois RR et al (1986) Vascular complications of inflammatory bowel disease. Mayo Clin Proc 61:140–145CrossRefPubMed
13.
Zurück zum Zitat Silverstein A, Present DH (1971) Cerebrovascular occlusions in relatively young patients with regional enteritis. JAMA 215:976–977CrossRefPubMed Silverstein A, Present DH (1971) Cerebrovascular occlusions in relatively young patients with regional enteritis. JAMA 215:976–977CrossRefPubMed
14.
Zurück zum Zitat Halliday CEW, Farthing MJG (1988) Arterial thrombosis in Crohn’s disease. Med J Aust 149:559–560PubMed Halliday CEW, Farthing MJG (1988) Arterial thrombosis in Crohn’s disease. Med J Aust 149:559–560PubMed
15.
Zurück zum Zitat Mevorach D, Goldberg Y, Gomori JM et al (1996) Antiphospholipid syndrome manifested by ischemic stroke in a patient with Crohn’s disease. J Clin Gastroenterol 22:141–143CrossRefPubMed Mevorach D, Goldberg Y, Gomori JM et al (1996) Antiphospholipid syndrome manifested by ischemic stroke in a patient with Crohn’s disease. J Clin Gastroenterol 22:141–143CrossRefPubMed
16.
Zurück zum Zitat Casella G, Antonelli E, Di Bella C, et al. (2013) Hyperhomocysteinemia in patients with Crohn’s disease. Tech Coloproctol Casella G, Antonelli E, Di Bella C, et al. (2013) Hyperhomocysteinemia in patients with Crohn’s disease. Tech Coloproctol
17.
Zurück zum Zitat Lange MC, Zamproni LN, Braatz V et al (2010) Ischemic stroke in a patient with Crohn’s disease: a confirmed paradoxical embolism mechanism. Arq Neuropsiquiatr 68:651–2CrossRefPubMed Lange MC, Zamproni LN, Braatz V et al (2010) Ischemic stroke in a patient with Crohn’s disease: a confirmed paradoxical embolism mechanism. Arq Neuropsiquiatr 68:651–2CrossRefPubMed
18.
Zurück zum Zitat Zöller B, Li X, Sundquist J, Sundquist K (2012) Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. BMC Neurol 12:41CrossRefPubMedCentralPubMed Zöller B, Li X, Sundquist J, Sundquist K (2012) Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. BMC Neurol 12:41CrossRefPubMedCentralPubMed
19.
Zurück zum Zitat White H, Boden-Albala B, Wang C et al (2005) Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 111:1327–1331CrossRefPubMed White H, Boden-Albala B, Wang C et al (2005) Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 111:1327–1331CrossRefPubMed
20.
Zurück zum Zitat Sharma VK, Tsivgoulis G, Teoh HL, Ong BK, Chan BP (2012) Stroke risk factors and outcomes among various Asian ethnic groups in Singapore. J Stroke Cerebrovasc Dis 21:299–304CrossRefPubMed Sharma VK, Tsivgoulis G, Teoh HL, Ong BK, Chan BP (2012) Stroke risk factors and outcomes among various Asian ethnic groups in Singapore. J Stroke Cerebrovasc Dis 21:299–304CrossRefPubMed
21.
Zurück zum Zitat Mehndiratta MM, Khan M, Mehndiratta P, Wasay M (2014) Stroke in Asia: geographical variations and temporal trends. J Neurol Neurosurg Psychiatry 85:1308–1312CrossRefPubMed Mehndiratta MM, Khan M, Mehndiratta P, Wasay M (2014) Stroke in Asia: geographical variations and temporal trends. J Neurol Neurosurg Psychiatry 85:1308–1312CrossRefPubMed
22.
Zurück zum Zitat Bai CH, Chen JR, Chiu HC et al (2007) Lower blood flow velocity, higher resistance index, and larger diameter of extracranial carotid arteries are associated with ischemic stroke independently of carotid atherosclerosis and cardiovascular risk factors. J Clin Ultrasound 35:322–330CrossRefPubMed Bai CH, Chen JR, Chiu HC et al (2007) Lower blood flow velocity, higher resistance index, and larger diameter of extracranial carotid arteries are associated with ischemic stroke independently of carotid atherosclerosis and cardiovascular risk factors. J Clin Ultrasound 35:322–330CrossRefPubMed
23.
Zurück zum Zitat Chuang SY, Bai CH, Chen JR et al (2011) Common carotid end-diastolic velocity and intima-media thickness joinly predict ischemic stroke in Taiwan. Stroke 42:1338–1344CrossRefPubMed Chuang SY, Bai CH, Chen JR et al (2011) Common carotid end-diastolic velocity and intima-media thickness joinly predict ischemic stroke in Taiwan. Stroke 42:1338–1344CrossRefPubMed
24.
Zurück zum Zitat Hall GC, Brown MM, Mo J et al (2004) Triptans in migraine. The risk of stroke, cardiovascular disease, and death in practice. Neurology 62:563–568CrossRefPubMed Hall GC, Brown MM, Mo J et al (2004) Triptans in migraine. The risk of stroke, cardiovascular disease, and death in practice. Neurology 62:563–568CrossRefPubMed
25.
Zurück zum Zitat Keller JJ, Wang J, Huang YL, Chou CC, Wang LH, Hsu JL, Bai CH, Chiou HY (2014) Increased risk of stroke among patients with ulcerative colitis: a population-based matched cohort study. Int J Colorectal Dis 29:805–812CrossRefPubMed Keller JJ, Wang J, Huang YL, Chou CC, Wang LH, Hsu JL, Bai CH, Chiou HY (2014) Increased risk of stroke among patients with ulcerative colitis: a population-based matched cohort study. Int J Colorectal Dis 29:805–812CrossRefPubMed
26.
Zurück zum Zitat Sankaran-Walters S, Macal M, Grishina I et al (2013) Sex differences matter in the gut: effect on mucosal immune activation and inflammation. Biol Sex Differ 4:10CrossRefPubMedCentralPubMed Sankaran-Walters S, Macal M, Grishina I et al (2013) Sex differences matter in the gut: effect on mucosal immune activation and inflammation. Biol Sex Differ 4:10CrossRefPubMedCentralPubMed
27.
Zurück zum Zitat Singh S, Singh H, Loftus EV Jr, Pardi DS (2013) Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol Singh S, Singh H, Loftus EV Jr, Pardi DS (2013) Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol
28.
Zurück zum Zitat Fakhoury M, Negrulj R, Mooranian A, Al-Salami H (2014) Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res 23(7):113–20CrossRef Fakhoury M, Negrulj R, Mooranian A, Al-Salami H (2014) Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res 23(7):113–20CrossRef
29.
Zurück zum Zitat Sartor RB (2006) Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3:390–407CrossRefPubMed Sartor RB (2006) Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3:390–407CrossRefPubMed
30.
Zurück zum Zitat Targan SR, Hanauer SB, van Deventer SJ et al (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn’s disease. Crohn’s Disease cA2 Study Group. N Engl J Med 337:1029–1035CrossRefPubMed Targan SR, Hanauer SB, van Deventer SJ et al (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn’s disease. Crohn’s Disease cA2 Study Group. N Engl J Med 337:1029–1035CrossRefPubMed
31.
Zurück zum Zitat Mannon PJ, Fuss IJ, Mayer L et al (2004) Anti-interleukin-12 antibody for active Crohn’s disease. N Engl J Med 351:2069–2079CrossRefPubMed Mannon PJ, Fuss IJ, Mayer L et al (2004) Anti-interleukin-12 antibody for active Crohn’s disease. N Engl J Med 351:2069–2079CrossRefPubMed
32.
Zurück zum Zitat Sawada K, Kusugami K, Suzuki Y et al (2005) Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case–control study with sham apheresis as placebo treatment. Am J Gastroenterol 100:1362–1369CrossRefPubMed Sawada K, Kusugami K, Suzuki Y et al (2005) Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case–control study with sham apheresis as placebo treatment. Am J Gastroenterol 100:1362–1369CrossRefPubMed
33.
Zurück zum Zitat Lichtiger S, Present DH, Kornbluth A et al (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330:1841–1845CrossRefPubMed Lichtiger S, Present DH, Kornbluth A et al (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330:1841–1845CrossRefPubMed
34.
Metadaten
Titel
Increased risk of stroke among patients with Crohn’s disease: a population-based matched cohort study
verfasst von
Joseph Jordan Keller
Jui Wang
Ya-Li Hwang
Chia-Chi Chou
Li-Hsuan Wang
Jung-Lung Hsu
Chyi-Huey Bai
Hung-Yi Chiou
Publikationsdatum
01.05.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Colorectal Disease / Ausgabe 5/2015
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-015-2132-y

Weitere Artikel der Ausgabe 5/2015

International Journal of Colorectal Disease 5/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.